Chaperone/Protein Folding, Peptidyl-prolyl cis-trans isomerase
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Cuervo et al. | no | yes: 0 | 
| Hassani et al. | no | yes: 0 | 
| Forrest at al. (metacyclic) | no | yes: 0 | 
| Forrest at al. (procyclic) | no | yes: 0 | 
| Silverman et al. | no | yes: 0 | 
| Pissara et al. | no | yes: 15 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Pires et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Silverman et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Jamdhade et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| DeepLoc | ||
| SignalP6 | yes | yes: 8, no: 7 | 
| NetGPI | no | yes: 0, no: 15 | 
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0005737 | cytoplasm | 2 | 2 | 
| GO:0110165 | cellular anatomical entity | 1 | 2 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Pescher et al. (upgregulation) | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| 
                        
                            Lahav et al. - mRNA 
                            - Protein 
                        
                     | 
                    
Related structures:
AlphaFold database: A4HYB4
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0000413 | protein peptidyl-prolyl isomerization | 7 | 2 | 
| GO:0006457 | protein folding | 2 | 2 | 
| GO:0006807 | nitrogen compound metabolic process | 2 | 2 | 
| GO:0008152 | metabolic process | 1 | 2 | 
| GO:0009987 | cellular process | 1 | 2 | 
| GO:0018193 | peptidyl-amino acid modification | 5 | 2 | 
| GO:0018208 | peptidyl-proline modification | 6 | 2 | 
| GO:0019538 | protein metabolic process | 3 | 2 | 
| GO:0036211 | protein modification process | 4 | 2 | 
| GO:0043170 | macromolecule metabolic process | 3 | 2 | 
| GO:0043412 | macromolecule modification | 4 | 2 | 
| GO:0044238 | primary metabolic process | 2 | 2 | 
| GO:0061077 | chaperone-mediated protein folding | 3 | 2 | 
| GO:0071704 | organic substance metabolic process | 2 | 2 | 
| GO:1901564 | organonitrogen compound metabolic process | 3 | 2 | 
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0003755 | peptidyl-prolyl cis-trans isomerase activity | 3 | 16 | 
| GO:0003824 | catalytic activity | 1 | 16 | 
| GO:0016853 | isomerase activity | 2 | 16 | 
| GO:0016859 | cis-trans isomerase activity | 3 | 16 | 
| GO:0140096 | catalytic activity, acting on a protein | 2 | 16 | 
| Leishmania | From | To | Domain/Motif | Score | 
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 108 | 110 | PF00675 | 0.280 | 
| CLV_NRD_NRD_1 | 69 | 71 | PF00675 | 0.366 | 
| CLV_PCSK_KEX2_1 | 108 | 110 | PF00082 | 0.280 | 
| CLV_PCSK_KEX2_1 | 69 | 71 | PF00082 | 0.367 | 
| CLV_PCSK_SKI1_1 | 183 | 187 | PF00082 | 0.422 | 
| CLV_PCSK_SKI1_1 | 49 | 53 | PF00082 | 0.403 | 
| DOC_CYCLIN_yCln2_LP_2 | 133 | 139 | PF00134 | 0.202 | 
| DOC_PP2B_LxvP_1 | 133 | 136 | PF13499 | 0.243 | 
| DOC_USP7_MATH_1 | 54 | 58 | PF00917 | 0.358 | 
| DOC_USP7_UBL2_3 | 143 | 147 | PF12436 | 0.174 | 
| DOC_WW_Pin1_4 | 107 | 112 | PF00397 | 0.298 | 
| LIG_14-3-3_CanoR_1 | 3 | 8 | PF00244 | 0.458 | 
| LIG_14-3-3_CanoR_1 | 37 | 42 | PF00244 | 0.391 | 
| LIG_Clathr_ClatBox_1 | 64 | 68 | PF01394 | 0.247 | 
| LIG_FHA_1 | 14 | 20 | PF00498 | 0.371 | 
| LIG_FHA_2 | 171 | 177 | PF00498 | 0.272 | 
| LIG_LIR_Apic_2 | 88 | 94 | PF02991 | 0.160 | 
| LIG_LIR_Gen_1 | 129 | 139 | PF02991 | 0.228 | 
| LIG_LIR_Gen_1 | 197 | 201 | PF02991 | 0.568 | 
| LIG_LIR_Gen_1 | 2 | 12 | PF02991 | 0.250 | 
| LIG_LIR_Gen_1 | 40 | 47 | PF02991 | 0.276 | 
| LIG_LIR_Nem_3 | 129 | 135 | PF02991 | 0.228 | 
| LIG_LIR_Nem_3 | 197 | 201 | PF02991 | 0.568 | 
| LIG_LIR_Nem_3 | 2 | 7 | PF02991 | 0.346 | 
| LIG_LIR_Nem_3 | 40 | 44 | PF02991 | 0.280 | 
| LIG_OCRL_FandH_1 | 3 | 15 | PF00620 | 0.286 | 
| LIG_PAM2_1 | 22 | 34 | PF00658 | 0.227 | 
| LIG_PDZ_Class_1 | 196 | 201 | PF00595 | 0.341 | 
| LIG_SH2_CRK | 41 | 45 | PF00017 | 0.254 | 
| LIG_SH2_CRK | 91 | 95 | PF00017 | 0.160 | 
| LIG_SH2_NCK_1 | 41 | 45 | PF00017 | 0.254 | 
| LIG_SH2_SRC | 132 | 135 | PF00017 | 0.262 | 
| LIG_SH2_STAP1 | 87 | 91 | PF00017 | 0.160 | 
| LIG_SH2_STAT5 | 132 | 135 | PF00017 | 0.273 | 
| LIG_SH2_STAT5 | 180 | 183 | PF00017 | 0.392 | 
| LIG_SH2_STAT5 | 198 | 201 | PF00017 | 0.476 | 
| LIG_SH2_STAT5 | 46 | 49 | PF00017 | 0.262 | 
| LIG_SH2_STAT5 | 87 | 90 | PF00017 | 0.187 | 
| LIG_SUMO_SIM_par_1 | 15 | 20 | PF11976 | 0.320 | 
| LIG_SUMO_SIM_par_1 | 22 | 27 | PF11976 | 0.277 | 
| LIG_TYR_ITIM | 196 | 201 | PF00017 | 0.379 | 
| MOD_CK1_1 | 170 | 176 | PF00069 | 0.287 | 
| MOD_CK1_1 | 29 | 35 | PF00069 | 0.416 | 
| MOD_CK1_1 | 6 | 12 | PF00069 | 0.380 | 
| MOD_CK2_1 | 170 | 176 | PF00069 | 0.282 | 
| MOD_GlcNHglycan | 167 | 170 | PF01048 | 0.527 | 
| MOD_GlcNHglycan | 173 | 176 | PF01048 | 0.299 | 
| MOD_GlcNHglycan | 56 | 59 | PF01048 | 0.311 | 
| MOD_GlcNHglycan | 60 | 63 | PF01048 | 0.339 | 
| MOD_GSK3_1 | 13 | 20 | PF00069 | 0.303 | 
| MOD_GSK3_1 | 167 | 174 | PF00069 | 0.367 | 
| MOD_GSK3_1 | 2 | 9 | PF00069 | 0.362 | 
| MOD_GSK3_1 | 22 | 29 | PF00069 | 0.301 | 
| MOD_GSK3_1 | 54 | 61 | PF00069 | 0.360 | 
| MOD_N-GLC_1 | 54 | 59 | PF02516 | 0.363 | 
| MOD_NEK2_1 | 17 | 22 | PF00069 | 0.317 | 
| MOD_NEK2_1 | 85 | 90 | PF00069 | 0.207 | 
| MOD_PIKK_1 | 109 | 115 | PF00454 | 0.340 | 
| MOD_PKA_2 | 2 | 8 | PF00069 | 0.473 | 
| MOD_Plk_1 | 26 | 32 | PF00069 | 0.523 | 
| MOD_Plk_1 | 54 | 60 | PF00069 | 0.369 | 
| MOD_Plk_4 | 13 | 19 | PF00069 | 0.327 | 
| MOD_Plk_4 | 26 | 32 | PF00069 | 0.202 | 
| MOD_Plk_4 | 6 | 12 | PF00069 | 0.391 | 
| MOD_ProDKin_1 | 107 | 113 | PF00069 | 0.298 | 
| MOD_SUMO_rev_2 | 144 | 152 | PF00179 | 0.188 | 
| TRG_DiLeu_BaEn_1 | 120 | 125 | PF01217 | 0.187 | 
| TRG_ENDOCYTIC_2 | 132 | 135 | PF00928 | 0.174 | 
| TRG_ENDOCYTIC_2 | 198 | 201 | PF00928 | 0.527 | 
| TRG_ENDOCYTIC_2 | 41 | 44 | PF00928 | 0.283 | 
| TRG_ER_diArg_1 | 107 | 109 | PF00400 | 0.254 | 
| TRG_NES_CRM1_1 | 113 | 127 | PF08389 | 0.303 | 
| Protein | Taxonomy | Sequence identity | Coverage | 
|---|---|---|---|
| A0A0N1HTT4 | Leptomonas seymouri | 30% | 100% | 
| A0A0N1II12 | Leptomonas seymouri | 66% | 100% | 
| A0A1X0P7N1 | Trypanosomatidae | 39% | 95% | 
| A0A3Q8IB31 | Leishmania donovani | 29% | 100% | 
| A0A3S5H764 | Leishmania donovani | 100% | 100% | 
| A0A3S5IR72 | Trypanosoma rangeli | 40% | 100% | 
| A4H677 | Leishmania braziliensis | 30% | 100% | 
| A4HA48 | Leishmania braziliensis | 76% | 100% | 
| A4HUK1 | Leishmania infantum | 29% | 100% | 
| D0A0P0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 33% | 100% | 
| E9AN99 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 100% | 
| E9AS47 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% | 
| Q09734 | Trypanosoma cruzi | 38% | 100% | 
| Q4QDB9 | Leishmania major | 96% | 100% | 
| Q4QHC5 | Leishmania major | 29% | 100% | 
| Q9JYI8 | Neisseria meningitidis serogroup B (strain MC58) | 28% | 74% |